News
09-08-2011, 05:11 AM
PDL BioPharma, Inc. today announced revenue guidance for the third quarter ending September 30, 2011, of approximately $83 million, as compared with actual results of $86 million for the third quarter of 2010, a three percent decrease.
More... (http://www.news-medical.net/news/20110908/PDL-third-quarter-revenue-decreases-325-to-2483-million.aspx)
More... (http://www.news-medical.net/news/20110908/PDL-third-quarter-revenue-decreases-325-to-2483-million.aspx)